CALR and Alzheimer disease: Previous studies have shown that the expression of calreticulin mRNA and protein in microglial cells in the white matter of Alzheimer’s-disease patients is significantly lower than that of healthy individuals, leading to an increase in oxidative stress and mitochondrial damage, which in turn causes the production of β-amyloid in nerve endings [34,35].